Screening Libraries

We achieve Target-Centric Tailored Chemical Collections through MOLÏNTIME®, a molecule discovery service that transforms raw chemical and biological data into a focused selection of target-specific, pharmacologically relevant molecules.

Starting from a target name, our platform curates, analyzes, and learns from public databases and patents to rapidly explore chemical spaces and generate novel molecular suggestions.

We integrate:

• Intelligent navigation across diverse and large chemical spaces
• Scaffold-based expansion
• Multi-criteria prioritization including novelty, potency, ADMET, and synthetic feasibility

to ensure that each molecule is not only plausible but also synthesizable, and ready for experimental screening.

Each collection contains:

• Hundreds of molecules (organized in chemical series)

• QSAR-predicted activity profiles against the target

• QSPR-based ADMET evaluations for early risk assessment

• Synthetic accessibility routes for rapid laboratory translation

• Target Novelty: Focus on drug targets with strong biological rationale but limited existing inhibitors.

• Accelerated Discovery: In silico pre-validated libraries shorten the hit-identification and hit-to-lead-to-candidate phases.

• Synthetic Readiness: Molecules are not just theoretical — each one has a practical synthetic path.

• Strategic Flexibility: Use as starting points for SAR exploration or hit optimization.

• Early-stage hit discovery and lead to candidate optimization in a wide variety of therapeutic areas

• SAR exploration across diverse molecular series

• Patent landscaping for freedom-to-operate assessment

• Collaborative R&D projects and licensing opportunities